Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Platelet Rich Plasma (PRP) is a growing field in regenerative medicine. It involves taking the patient�s own blood, extracting the
platelets from that blood and then injecting the platelets into affected areas. Platelets have the ability to produce several growth
factors which may enhance tissue healing. A review by Taylor et al. in 2011 showed 7/13 articles showing positive results for soft tissue
type injuries like achilles tendinopathy, rotator cuff injuries, patellar and elbow tendonitis. Cochrane review in 2013 showed trending
results to some improvement in PRP injections. However, the recommendation was that there is insufficient evidence to support the
use of PRP injections for musculoskeletal soft tissue injuries. Since that time 292 additional articles have been published. Guatam et
al. compared steroid injections versus PRP for recalcitrant lateral epicondylitis and showed that PRP enabled biological healing of the
tendon, whereas corticosteroid injections provided short term symptomatic relief but resulted in tendon degeneration. Ford et al. in
2015 found that for recalcitrant lateral epicondylitis PRP and surgery had similar positive outcomes. In conclusion there is emerging
evidence to support the use of platelet-rich therapy for treating musculoskeletal soft tissue injuries, particularly when conservative
treatment has failed and the next treatment option is an invasive surgical procedure